Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
16 hedge funds and large institutions have $109K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
40% more capital invested
Capital invested by funds: $77.7K → $109K (+$31.1K)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$56 |
CTV.WS Hedge Fund Activity: Q2 2024 in Review
16 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q2 2024, worth a combined $109K — up 40% from $77.7K a quarter earlier.
Fund positioning in CTV.WS was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $1.36K. The largest seller was First Manhattan, exiting entirely with an estimated $56 sold.
- 16 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $109K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2024, up 40% quarter-over-quarter.
- 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2024 was Cantor Fitzgerald, an estimated $1.36K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2024 was First Manhattan, an estimated $56 sold.
Based on aggregated 13F filings for Q2 2024.